Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 1
2020 5
2021 6
2022 6
2023 3
2024 2
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M; PROFILE Study Group. Noor NM, et al. Among authors: kok kb. Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22. Lancet Gastroenterol Hepatol. 2024. PMID: 38402895 Free PMC article. Clinical Trial.
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025.
Moran GW, Gordon M, Sinopolou V, Radford SJ, Darie AM, Vuyyuru SK, Alrubaiy L, Arebi N, Blackwell J, Butler TD, Chew T, Colwill M, Cooney R, De Marco G, Din S, Din S, Feakins R, Gasparetto M, Gordon H, Hansen R, Kok KB, Lamb CA, Limdi J, Liu E, Loughrey MB, McGonagle D, Patel K, Pavlidis P, Selinger C, Shale M, Smith PJ, Subramanian S, Taylor SA, Tun GSZ, Verma AM, Wong NACS; IBD guideline development group. Moran GW, et al. Among authors: kok kb. Gut. 2025 Jun 23;74(Suppl 2):s1-s101. doi: 10.1136/gutjnl-2024-334395. Gut. 2025. PMID: 40550582 Free article.
Fecal Calprotectin in Gastrointestinal Disease.
Murray J, Kok KB, Ayling RM. Murray J, et al. Among authors: kok kb. Clin Chem. 2023 Jul 5;69(7):699-710. doi: 10.1093/clinchem/hvad051. Clin Chem. 2023. PMID: 37228058
IBD in pregnancy: recent advances, practical management.
Selinger CP, Nelson-Piercy C, Fraser A, Hall V, Limdi J, Smith L, Smith M, Nasur R, Gunn M, King A, Mohan A, Mulgabal K, Kent A, Kok KB, Glanville T. Selinger CP, et al. Among authors: kok kb. Frontline Gastroenterol. 2020 May 19;12(3):214-224. doi: 10.1136/flgastro-2019-101371. eCollection 2021. Frontline Gastroenterol. 2020. PMID: 33912333 Free PMC article. Review.
Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study.
Radia C, Danso Y, Ritchie S, Hale M, Elford AT, Patel C, Hicks L, Kalyanji S, Dong C, Yeung K, Yeo JH, Allah-Ditta M, Bishara M, Sethi-Arora K, Pillay L, Johnston EL, Rudling R, Rees F, Harvey P, Trodden-Mittnacht H, Davis E, Fraser A, Sawan NJ, Hussain MA, Campbell R, George B, Rawcliffe M, Choon XY, Shah K, Al-Zarrad D, Toft J, Chhabra P, Burr N, Hewitt A, Kumar R, McCartney S, Rosiou K, Dhar A, Lees CW, Lamb CA, Speight A, Ahmad T, Limdi J, Raine T, Walsh A, Cooney R, Harrow P, Patel K, Samaan M, Pavlidis P, Kent A, Selinger C, Kok KB. Radia C, et al. Among authors: kok kb. J Crohns Colitis. 2025 Sep 28;19(9):jjaf154. doi: 10.1093/ecco-jcc/jjaf154. J Crohns Colitis. 2025. PMID: 40833970
Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn's Disease Commencing Biological Therapy: The Motility Study.
Plumb AA, Moran G, Chowdhury K, Ahmed N, Philpott S, Ahmad T, Bloom S, Hart A, Jacobs I, Menys A, Mooney P, Tolan D, Travis S, Bhagwanani A, Bhatnagar G, Boone D, Franklin J, Gangi-Burton A, Hameed M, Helbren E, Hosseini-Ardehali F, Hyland R, Kilic Y, Kumar S, Lambie H, Mohsin M, Patel A, Rahman S, Sakai N, Sidhu H, Thomson E, Ahmed S, Bannur Chikkeragowda U, Barratt N, Beeston T, Fitzke H, Gibbons N, Godfrey E, Gupta A, Higginson A, Isaac E, Kok KB, Langlands S, Parkes M, Patel J, Patel K, Patel K, Patodi N, Pollok R, Przemiosolo R, Robinson C, Thoua N, Wadke A, Halligan S, Taylor SA; MOTILITY study co-authors. Plumb AA, et al. Among authors: kok kb. Inflamm Bowel Dis. 2025 Sep 1;31(9):2438-2450. doi: 10.1093/ibd/izaf023. Inflamm Bowel Dis. 2025. PMID: 40053679 Free PMC article.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Among authors: kok kb. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T; CLARITY IBD study. Lin S, et al. Among authors: kok kb. Nat Commun. 2022 Mar 16;13(1):1379. doi: 10.1038/s41467-022-28517-z. Nat Commun. 2022. PMID: 35296643 Free PMC article.
24 results